EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits

Bryan Kromenacker iD, Walid Yassin iD, Matcheri Keshavan, David Parker iD, Vishal J Thakkar iD, Godfrey Pearlson iD, Sarah Keedy, Jennifer McDowell, Elliot Gershon, Elena Ivleva, S Kristian Hill, Brett A Clementz und 1 weitere

Schizophrenia Bulletin · 08.09.2025 · 51 (5) · 1454-1463

DOI: 10.1093/schbul/sbae219 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Schizophrenia Bulletin, online erschienen am 08.01.2025. Verfasst von Bryan Kromenacker und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX 75390, United States. Hauptthemen laut MEDLINE: Psychotic Disorders, Schizophrenia, Exposome, Severity of Illness Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIMH NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Investigations of causal pathways for psychosis can be guided by the identification of environmental risk factors. A recently developed composite risk tool, the exposome score for schizophrenia (ES-SCZ), which controls for intercorrelations between risk factors, has shown fair to good performance. We tested the transdiagnostic psychosis classifier performance of the ES-SCZ with the Bipolar-Schizophrenia Network for Intermedial Phenotypes data and examined its relationship with clinical-level outcomes. Study Design We computed the case-control classifier performance for the ES-SCZ from cross-sectional data on 1055 volunteers with psychotic diagnoses (schizophrenia, schizoaffective, bipolar psychosis) and 510 controls. Multivariate regression models were used to control for the correlations between outcomes and to correct for the effects of age, sex, and family socioeconomic status across outcomes. We estimated association for the ES-SCZ with psychosis and mood symptom severity, the 5-factor model of personality, and function across biologically defined biotypes, traditional diagnostic categories, and controls. Study Results ES-SCZ classifier performance for psychosis was fair to good. ES-SCZ associations with personality factor scores were qualitatively similar between psychosis groups and controls with decreased conscientiousness and agreeableness and increased neuroticism. The patterns of associations between ES-SCZ and symptoms differed across biotypes and diagnoses. Biotype 3 and bipolar disorder had consistent within-group associations where greater exposome score predicted more severe symptoms and worse function.

Conclusions

ES-SCZ performance was consistent with previous reports in this transdiagnostic psychosis sample (adjusted odds ratio: 3.331 [2.834, 3.915], P < .001; area under the curve: 0.762 [0.735, 0.789]). Individual differences in ES-SCZ magnitude may be useful for investigating causal pathways between developmentally relevant exposures and symptomatic expression of psychosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotic DisordersSchizophreniaExposomeSeverity of Illness IndexRisk AssessmentCase-Control StudiesCross-Sectional StudiesPhenotypeRegression AnalysisModels, PsychologicalReproducibility of ResultsOdds RatioRisk FactorsSymptom BurdenClinical RelevanceHumansMaleFemaleAdultMiddle AgedPersonality Inventory

Stichwörter der Autor:innen

B-SNIPRDoCbiotypesenvironmental riskindividual differencestrauma

Autor:innen und Institutionen

  • Department of Psychiatry, UT Southwestern Medical Center, Dallas, TX 75390, United States.
  • Department of Psychiatry, Harvard University, Cambridge, MA 02138, United States.
  • Department of Psychology and Neuroscience, University of Georgia, Athens, GA 30602, United States.
  • Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, United States.
  • Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, United States.
  • Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL 60637, United States.

ORCID-Profile: Bryan Kromenacker, Walid Yassin, David Parker, Vishal J Thakkar, Godfrey Pearlson

Förderung

  • NIH HHS
  • NIMH NIH HHS
  • NCATS NIH HHS
  • NIH

Zitieren

APA

Kromenacker, B., Yassin, W., Keshavan, M., Parker, D., Thakkar, V. J., Pearlson, G., Keedy, S., McDowell, J., Gershon, E., Ivleva, E., Hill, S. K., Clementz, B. A., & Tamminga, C. A. (2025). Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits. Schizophrenia Bulletin, 51(5), 1454-1463. https://doi.org/10.1093/schbul/sbae219

Vancouver

Kromenacker B, Yassin W, Keshavan M, Parker D, Thakkar VJ, Pearlson G, et al. Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits. Schizophrenia Bulletin. 2025;51(5):1454-1463. doi:10.1093/schbul/sbae219

BibTeX
@article{Kromenacker2025,
  author = {Kromenacker, Bryan and Yassin, Walid and Keshavan, Matcheri and Parker, David and Thakkar, Vishal J and Pearlson, Godfrey and Keedy, Sarah and McDowell, Jennifer and Gershon, Elliot and Ivleva, Elena and Hill, S Kristian and Clementz, Brett A and Tamminga, Carol A},
  title = {Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  volume = {51},
  number = {5},
  pages = {1454--1463},
  doi = {10.1093/schbul/sbae219}
}
Kostenlos starten →